# Correction: Was kommt nach CDK4/6-Inhibition? Perspektiven beim fortgeschrittenen Mammakarzinom

**Authors:** Vanessa Castagnaviz, Anna Fenzl, Michael Gnant, Rupert Bartsch

PMC · DOI: 10.1007/s00508-025-02622-7 · Wiener Klinische Wochenschrift · 2025-09-22

## Full-text entities

- **Chemicals:** DFP (MESH:D007531)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12592315/full.md

---
Source: https://tomesphere.com/paper/PMC12592315